2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 Announcements Directorate Change (37.1k) Directorate Change (177.2k) Dealings in securities (55.6k) Dealings in securities (72.6k) Distribution of the integrated annual report, notice of annual general meeting, and B-BBEE annual compliance report (96.2k) Audited Annual Consolidated Results for the twelve months ended 28 February 2026 (160.3k) Directorate Change (178.4k) Dealings in securities by an associate of a director (218.2k) Dealings in securities by an associate of a director (100.7k) Dealings in securities by an associate of a director (99.2k) Trading Update For The Period 1 September 2025 - 16 February 2026 (75.6k) Dealings in securities (99.4k) Dealings in securities (99.4k) Dealings in securities (99.4k) Dealings in securities (99.3k) Announcements Directorate change- Company founder (87.8k) Notification of change in beneficial interest (101.8k) Interim consolidated financial results for the six months ended 31 August 2025 (111.6k) Directorate Change (91.2k) Notification of change in beneficial interest (101.7k) Dealings in securities (52.7k) Change in transfer secretary (82.6k) Notification of change in beneficial interest (102k) Results of the annual general meeting of Dis-Chem pharmacies limited held at 10.00 on Thursday the 31st of July 2025 (182.3k) Dealings in securities (99.4k) Distribution of the integrated annual report, notice of annual general meeting, and B-BBEE annual compliance report (102k) Announcement relating to the restructuring of share portfolio, director’s dealing and changes in beneficial interest. (110.9k) Audited Annual Consolidated Results for the twelve months ended 28 February 2025 (86.2k) Trading statement (44.2k) Dealing in securities by an associate of a prescribed officer (101k) Trading update 1 September 2024 - 31 January 2025 (54.6k) Announcements Dealings in securities (101.1k) Interim results for the half-year ended 31 August 2024 (135.6k) Dealings in securities (97.9k) Dealings in securities (100.3k) Dealing in securities by an associate of a prescribed officers (101.9k) Dealings in securities (101k) Results of the annual general meeting (84.3k) Dealings in securities (100.4k) Dealings in securities (75.1k) Dealing in securities by an associate of a prescribed officers (100.6k) Related party transaction- availability of Fairness Opinion (59.4k) Fairness Opinion (371.6k) Dealings in securities pursuant to an employee share scheme (39.4k) Dealings in securities (106.5k) Distribution of integrated annual report; notice of annual general meeting; and b-bbee annual compliance report (103.3k) Dealing in securities by associates of directors and prescribed officers (121.2k) Audited Annual Consolidated Results for the twelve months ended 29 February 2024 (121.8k) Announcement regarding a small related party transaction between Dis-Chem, OneSpark proprietary limited and OneSpark holdings inc. (85.4k) Management retention scheme: dealing in securities by directors, associates of directors and prescribed officers (113.5k) Trading update (121k) Dealings in securities (74.7k) Dealings in securities (101.2k) Dealings in securities (75k) Related Party Transaction- Availability of Fairness Opinion (60.5k) Fairness Opinion (131.2k) Dealings in securities by associates of directors and notification of change in beneficial interest. (113k) Announcement regarding a related party transaction (98.5k) Announcements Notification of change in beneficial interest (102.4k) Dealings in shares by an associate of a prescribed officer (100.3k) Dealings in shares by an associate of a prescribed officer (99.9k) Dealings in shares by a director (97.9k) Results of the Annual General Meeting (104.8k) Distribution of IAR and AFS, no change statement, notice of AGM and B-BBEE report (102.3k) Change in beneficial interest (93.1k) Dealings in securities (103.7k) FY2023 Reviewed Annual Condensed Consolidated Results (131.1k) Trading update, CEO and CFO succession and acquisition of distribution centre (131.3k) Dealings in securities (95.6k) Trading update (175.8k) Dealing in shares pursuant to an employee share scheme (99.1k) Announcements Interim Condensed Consolidated Financial Results for the six months ended 31 August 2022 (66k) Trading update (115.8k) Directorate change to Board committees (70.3k) Dealings in shares by an associate (99.1k) Dealings in shares by an associate (98.1k) Results of the Annual General Meeting (119.5k) Directorate change (102.3k) Dealing in shares pursuant to an employee share scheme (97.8k) Distribution of IAR and AFS, no change statement, notice of AGM and BEE (72.1k) Reviewed Annual Condensed Consolidated Results for the twelve months ended 28 February 2022 (61.3k) Trading update (131.5k) Directorate change to Board committees (73k) Dealings in shares by an associate (98.6k) Change in beneficial interest (98.6k) Trading update- 21 weeks to 26 January 2022 (95k) Availability of fairness opinion (68.7k) Dealings in shares by an associate (131.7k) Related party transaction (76.9k) Dealings in shares by an associate (131.7k) Announcements Dealings in shares by an associate (98.4k) Directorate change (71.2k) Interim Condensed Consolidated Financial Results for the six months ended 31 August 2021 (41.4k) Trading statement and voluntary announcement relating to Kaelo acquisition (114.5k) Voluntary announcement relating to Medicare acquisition (100.4k) Change in beneficial interest (97.9k) Update on BEE transaction (129.5k) Dealings in securities and change in beneficial ownership (112.6k) Result of bookbuild (159.2k) Trading update 1 March 2021 - 6 August 2021 (178.8k) Bookbuild (149k) Results of the Annual General Meeting (102.5k) Distribution of IAR, no change statement and notice of AGM (17.5k) Notification of change in external auditors (99.3k) Dealings in shares by an associate of a prescribed officer (97.7k) Dealings in securities (97.1k) Dealings in Dis-Chem shares by a director (71.2k) FY2021 Results (45.9k) FY2021 provisional reviewed annual consolidated results (45.3k) Company Secretary Change (93.4k) Trading update- 22 weeks to 2 February 2021 (64.5k) Dealings in shares by an associate (97k) Dealings in shares by an associate (100.9k) Directorate change (92.9k) Announcements Voluntary announcement relating to acquisitions (145.2k) 1H21 Results (40.4k) Directorate change (91.8k) Trading update- 24 weeks to 15 August 2020 (162.8k) Results of the Annual General Meeting (77.3k) Publication of IAR, no change statement, notice of AGM and B-BBEE compliance report (110.5k) FY2020 provisional reviewed annual condensed consolidated results (42.6k) Voluntary announcement relating to the acquisition of Baby City (117.9k) Trading update- 22 weeks to 2 February 2020 (161k) Dealings in Dis-Chem shares by an associate of director (60.6k) Announcements Dealings in Dis-Chem shares by an associate of director (61.4k) Unaudited interim condensed consolidated results for the six months ended 31 August 2019 (44.1k) Trading update (557.7k) Trading update for the five months ended 31 July 2019 (147.7k) Dealing in Dis-Chem Shares by an Associate of a Director (60.1k) Results of the Annual General Meeting (81.7k) Notification in terms of the Companies Act and the JSE Listings Requirements (113.6k) Distribution of Integrated Annual Report, No Change Statement, Notice of AGM and B-BBEE Compliance Report (102.6k) Provisional Reviewed Annual Condensed Consolidated Results (60.5k) Trading Update for the 22 weeks to 2 February 2019 and an update on the Groups Industrial Action (508.5k) Announcements Reviewed interim condensed consolidated results for the six months ended 31 August 2018 (59.6k) Results Of The Annual General Meeting (134.9k) Trading Update For The Four-Months Ended 30 June 2018 And Earnings Guidance For FY2019 (381.8k) Distribution Of Integrated Annual Report No Change Statement Notice Of AGM And B-BBEE Annual Compliance Report (345.8k) Dealings in Securities (151.9k) Dealings in Securities (112.2k) Provisional reviewed annual condensed consolidated results for the year ended 28 February 2018 (24.4k) Directors dealing in securities (67.8k) Trading Update for the 22 weeks to 2 February 2018 (106.2k) Announcements Dealings in securities (71.8k) Dealing in securities (67.6k) Results of accelerated bookbuild (274.3k) Announcement in relation to an accelerated bookbuild (215.8k) Interim results for the six months ended 31 August 2017 (24.8k) Trading statement for the six months ended 31 August 2017 (192.7k) Results of the Annual General Meeting (93.2k) Distribution Of Integrated Annual Report No Change Statement And Notice Of Annual General Meeting (183.2k) Provisional Reviewed Annual Condensed Consolidated Results (26.8k) Trading Statement (69.8k) Appointment of non-executive director (182.2k) Trading Update for the 22 weeks to 29 January 2017 (149.8k)
